60 128
Medical Institute and the National Institutes of Health (R01 DA036858). B.R.C.
received support from the US National Heart, Lung, and Blood Institute, the
National Institutes of Health (U01-HL100406, U01-GM09614, R01-
HL108677, U01-HL098179, U01-HL099997, P01-HL089707, R01HL130533,
and R01-HL060664), and an Agilent University Relations Grant.
Received: August 20, 2015
Revised: December 21, 2015
Accepted: January 24, 2016
Published: March 10, 2016
REFERENCES
Apa´ ti, A´ ., Pa´ szty, K., Heged
}
us, L., Kolacsek, O., Orba´ n, T.I., Erdei, Z.,
Szebe´ nyi, K., Pe´ ntek, A., Enyedi, A´ ., and Sarkadi, B. (2013). Characterization
of calcium signals in human embryonic stem cells and in their differentiated
offspring by a stably integrated calcium indicator protein. Cell. Signal.
25
,
752–759.
Armanios, M., Chen, J.-L., Chang, Y.-P.C., Brodsky, R.A., Hawkins, A., Griffin,
C.A., Eshleman, J.R., Cohen, A.R., Chakravarti, A., Hamosh, A., and Greider,
C.W. (2005). Haploinsufficiency of telomerase reverse transcriptase leads to
anticipation in autosomal dominant dyskeratosis congenita. Proc. Natl. Acad.
Sci. USA
102
, 15960–15964.
Boettcher, M., and McManus, M.T. (2015). Choosing the Right Tool for the Job:
RNAi, TALEN, or CRISPR. Mol. Cell
58
, 575–585.
Bolouri, H., and Davidson, E.H. (2003). Transcriptional regulatory cascades in
development: initial rates, not steady state, determine network kinetics. Proc.
Natl. Acad. Sci. USA
100
, 9371–9376.
Chen, T.-W., Wardill, T.J., Sun, Y., Pulver, S.R., Renninger, S.L., Baohan, A.,
Schreiter, E.R., Kerr, R.A., Orger, M.B., Jayaraman, V., et al. (2013).
Ultrasensitive fluorescent proteins for imaging neuronal activity. Nature
499
,
295–300.
Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P.D., Wu, X.,
Jiang, W., Marraffini, L.A., and Zhang, F. (2013). Multiplex genome engineering
using CRISPR/Cas systems. Science
339
, 819–823.
Davidson, B.L., and McCray, P.B., Jr. (2011). Current prospects for RNA inter-
ference-based therapies. Nat. Rev. Genet.
12
, 329–340.
Doench, J.G., Hartenian, E., Graham, D.B., Tothova, Z., Hegde, M., Smith, I.,
Sullender, M., Ebert, B.L., Xavier, R.J., and Root, D.E. (2014). Rational design
of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat.
Biotechnol.
32
, 1262–1267.
Doudna, J.A., and Charpentier, E. (2014). Genome editing. The new frontier of
genome engineering with CRISPR-Cas9. Science
346
, 1258096.
Gaj, T., Gersbach, C.A., and Barbas, C.F., 3rd (2013). ZFN, TALEN, and
CRISPR/Cas-based methods for genome engineering. Trends Biotechnol.
31
, 397–405.
Gilbert, L.A., Larson, M.H., Morsut, L., Liu, Z., Brar, G.A., Torres, S.E., Stern-
Ginossar, N., Brandman, O., Whitehead, E.H., Doudna, J.A., et al. (2013).
CRISPR-mediated modular RNA-guided regulation of transcription in eukary-
otes. Cell
154
, 442–451.
Gilbert, L.A., Horlbeck, M.A., Adamson, B., Villalta, J.E., Chen, Y., Whitehead,
E.H., Guimaraes, C., Panning, B., Ploegh, H.L., Bassik, M.C., et al. (2014).
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation.
Cell
159
, 647–661.
Gonza´ lez, F., Zhu, Z., Shi, Z.-D., Lelli, K., Verma, N., Li, Q.V., and Huangfu, D.
(2014). An iCRISPR platform for rapid, multiplexable, and inducible genome
editing in human pluripotent stem cells. Cell Stem Cell
15
, 215–226.
Haussecker, D. (2012). The business of RNAi therapeutics in 2012. Mol. Ther.
Nucleic Acids
1
, e8.
Hayashi, Y., Caboni, L., Das, D., Yumoto, F., Clayton, T., Deller, M.C., Nguyen,
P., Farr, C.L., Chiu, H.-J., Miller, M.D., et al. (2015). Structure-based discovery
of NANOG variant with enhanced properties to promote self-renewal and
reprogramming of pluripotent stem cells. Proc. Natl. Acad. Sci. USA
112
,
4666–4671.
Hockemeyer, D., Wang, H., Kiani, S., Lai, C.S., Gao, Q., Cassady, J.P., Cost,
G.J., Zhang, L., Santiago, Y., Miller, J.C., et al. (2011). Genetic engineering of
human pluripotent cells using TALE nucleases. Nat. Biotechnol.
29
, 731–734.
Huebsch, N., Loskill, P., Mandegar, M.A., Marks, N.C., Sheehan, A.S., Ma, Z.,
Mathur, A., Nguyen, T.N., Yoo, J.C., Judge, L.M., et al. (2015). Automated
video-based analysis of contractility and calcium flux in human-induced
pluripotent stem cell-derived cardiomyocytes cultured over different spatial
scales. Tissue Eng. Part C Methods
21
, 467–479.
Jackson, A.L., Bartz, S.R., Schelter, J., Kobayashi, S.V., Burchard, J., Mao, M.,
Li, B., Cavet, G., and Linsley, P.S. (2003). Expression profiling reveals off-tar-
get gene regulation by RNAi. Nat. Biotechnol.
21
, 635–637.
Kearns, N.A., Genga, R.M.J., Enuameh, M.S., Garber, M., Wolfe, S.A., and
Maehr, R. (2014). Cas9 effector-mediated regulation of transcription and dif-
ferentiation in human pluripotent stem cells. Development
141
, 219–223.
Kim, H., and Kim, J.-S. (2014). A guide to genome engineering with program-
mable nucleases. Nat. Rev. Genet.
15
, 321–334.
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., and Salzberg, S.L.
(2013a). TopHat2: accurate alignment of transcriptomes in the presence of
insertions, deletions and gene fusions. Genome Biol.
14
, R36.
Kim, Y., Kweon, J., Kim, A., Chon, J.K., Yoo, J.Y., Kim, H.J., Kim, S., Lee, C.,
Jeong, E., Chung, E., et al. (2013b). A library of TAL effector nucleases span-
ning the human genome. Nat. Biotechnol.
31
, 251–258.
Krueger, U., Bergauer, T., Kaufmann, B., Wolter, I., Pilk, S., Heider-Fabian, M.,
Kirch, S., Artz-Oppitz, C., Isselhorst, M., andKonrad, J.(2007).Insights intoeffec-
tive RNAi gained from large-scale siRNA validation screening. Oligonucleotides
17
, 237–250.
Lian, X., Hsiao, C., Wilson, G., Zhu, K., Hazeltine, L.B., Azarin, S.M., Raval,
K.K., Zhang, J., Kamp, T.J., and Palecek, S.P. (2012). Robust cardiomyocyte
differentiation from human pluripotent stem cells via temporal modulation of
canonical Wnt signaling. Proc. Natl. Acad. Sci. USA
109
, E1848–E1857.
Liao, Y., Smyth, G.K., and Shi, W. (2013). The Subread aligner: fast, accurate
and scalable read mapping by seed-and-vote. Nucleic Acids Res.
41
, e108.
Lombardo, A., Cesana, D., Genovese, P., Di Stefano, B., Provasi, E., Colombo,
D.F., Neri, M., Magnani, Z., Cantore, A., Lo Riso, P., et al. (2011). Site-specific
integration and tailoring of cassette design for sustainable gene transfer. Nat.
Methods
8
, 861–869.
Ludwig, T.E., Bergendahl, V., Levenstein, M.E., Yu, J., Probasco, M.D., and
Thomson, J.A. (2006). Feeder-independent culture of human embryonic stem
cells. Nat. Methods
3
, 637–646.
Mali, P., Yang, L., Esvelt, K.M., Aach, J., Guell, M., DiCarlo, J.E., Norville, J.E.,
and Church, G.M. (2013). RNA-guided human genome engineering via Cas9.
Science
339
, 823–826.
Marston, S., Copeland, O., Gehmlich, K., Schlossarek, S., and Carrier, L.
(2012). How do MYBPC3 mutations cause hypertrophic cardiomyopathy?
J. Muscle Res. Cell Motil.
33
, 75–80.
McFadden, D.G., Barbosa, A.C., Richardson, J.A., Schneider, M.D.,
Srivastava, D., and Olson, E.N. (2005). The Hand1 and Hand2 transcription
factors regulate expansion of the embryonic cardiac ventricles in a gene
dosage-dependent manner. Development
132
, 189–201.
Minami, S.S., Min, S.-W., Krabbe, G., Wang, C., Zhou, Y., Asgarov, R., Li, Y.,
Martens, L.H., Elia, L.P., Ward, M.E., et al. (2014). Progranulin protects against
amyloid
b
deposition and toxicity in Alzheimer’s disease mouse models. Nat.
Med.
20
, 1157–1164.
Miyaoka, Y., Chan, A.H., Judge, L.M., Yoo, J., Huang, M., Nguyen, T.D.,
Lizarraga, P.P., So, P.-L., and Conklin, B.R. (2014). Isolation of single-base
genome-edited human iPS cells without antibiotic selection. Nat. Methods
11
, 291–293.
Oyer, J.A., Chu, A., Brar, S., and Turker, M.S. (2009). Aberrant epigenetic
silencing is triggered by a transient reduction in gene expression. PLoS ONE
4
, e4832.
Qi, L.S., Larson, M.H., Gilbert, L.A., Doudna, J.A., Weissman, J.S., Arkin, A.P.,
and Lim, W.A. (2013). Repurposing CRISPR as an RNA-guided platform for
sequence-specific control of gene expression. Cell
152
, 1173–1183.
552
Cell Stem Cell
18
, 541–553, April 7, 2016
ª
2016 Elsevier Inc.